Medicare Enrolled
Dr. Daisy Acevedo Morales, MD
Endocrinology · South Miami, FL
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Acevedo Morales from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Acevedo Morales?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Acevedo Morales
Dr. Daisy Acevedo Morales is an endocrinology specialist in South Miami, FL, with 17 years of NPI registration. Based on federal Medicare data, Dr. Acevedo Morales performed 1,190 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Acevedo Morales received a total of $8,976 from 45 pharmaceutical and/or device companies across 382 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Acevedo Morales is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 17 years of NPI registration
▲ Top 39% volume in FL
$8,976 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 112978 | Clear | January 31, 2028 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary — 2023
Medicare Utilization ↗1,190
Medicare services
Top 39% in FL for endocrinology
Not available
Unique patients (not deduplicated)
$48
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 720 | $19 | $46 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
157 | $99 | $348 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
55 | $140 | $541 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
45 | $8 | $9 |
| New patient office visit, complex (60-74 min) | 43 | $161 | $681 |
| Ultrasound of head and neck soft tissue This procedure uses sound waves to create images of the soft tissues in the head and neck area. It allows for the visualization of structures beneath the skin without using radiation. |
41 | $95 | $369 |
| Continuous glucose monitoring with interpretation This procedure involves monitoring blood sugar levels in tissue fluid using a sensor placed under the skin, along with the interpretation and reporting of the results. |
26 | $30 | $140 |
| Blood glucose test using hand-held instrument A test that measures the level of sugar in the blood using a portable device. The result helps monitor blood glucose levels. |
25 | $3 | $10 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
25 | $78 | $236 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
25 | $154 | $468 |
| Ultrasound-guided fine needle aspiration biopsy, first lesion A biopsy procedure where a thin needle is used to collect tissue samples from a growth, guided by ultrasound imaging. This code applies to the first lesion or mass sampled during the session. |
16 | $120 | $729 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
12 | $59 | $240 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$8,976
Total received (2018-2024)
Avg $1,282/year across 7 years
Top 33% in FL for endocrinology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
45
Companies
382
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,947
2023
$2,215
2022
$584
2021
$929
2020
$318
2019
$495
2018
$487
Payments by company (2024)
Lilly USA, LLC
$647
Novo Nordisk Inc
$511
Amgen Inc.
$364
Insulet Corporation
$291
RECORDATI_RARE_DISEASES_INC.
$205
Xeris Pharmaceuticals, Inc.
$174
Radius Health, Inc.
$163
SANOFI-AVENTIS U.S. LLC
$162
Mannkind Corporation
$147
Corcept Therapeutics
$137
Abbott Laboratories
$133
Boehringer Ingelheim Pharmaceuticals, Inc.
$123
ABBVIE INC.
$120
BETA BIONICS, INC.
$105
Bayer Healthcare Pharmaceuticals Inc.
$103
Dexcom, Inc.
$100
Amneal Pharmaceuticals LLC
$81
Tandem Diabetes Care, Inc.
$67
Antares Pharma, Inc.
$62
IBSA Pharma Inc.
$40
Kyowa Kirin, Inc.
$26
Alvogen Inc
$24
Chiesi USA, Inc.
$22
Verity Pharmaceuticals Inc.
$21
Embecta Corp.
$21
VIVUS LLC
$21
PFIZER INC.
$20
Medtronic, Inc.
$18
Astellas Pharma US Inc
$18
Acella Pharmaceuticals, LLC
$15
CeQur Corporation
$9
Top 3 companies account for 38.6% of 2024 payments
All-time payments by company (2018-2024) ›
Novo Nordisk Inc
$1,425
Lilly USA, LLC
$974
Amgen Inc.
$466
SANOFI-AVENTIS U.S. LLC
$454
Janssen Pharmaceuticals, Inc
$441
Insulet Corporation
$355
Dexcom, Inc.
$350
Bayer Healthcare Pharmaceuticals Inc.
$314
AstraZeneca Pharmaceuticals LP
$311
Tandem Diabetes Care, Inc.
$306
Boehringer Ingelheim Pharmaceuticals, Inc.
$294
RECORDATI_RARE_DISEASES_INC.
$268
Xeris Pharmaceuticals, Inc.
$250
Mannkind Corporation
$242
Radius Health, Inc.
$235
MannKind Corporation
$211
Abbott Laboratories
$206
Corcept Therapeutics
$188
PFIZER INC.
$174
Amneal Pharmaceuticals LLC
$159
CeQur Corporation
$145
ABBVIE INC.
$120
Shire North American Group Inc
$119
Medtronic MiniMed, Inc.
$109
BETA BIONICS, INC.
$105
AbbVie Inc.
$95
Embecta Corp.
$85
IBSA Pharma Inc.
$76
Supernus Pharmaceuticals, Inc.
$67
Antares Pharma, Inc.
$62
Kyowa Kirin, Inc.
$49
Alvogen Inc
$46
Medtronic, Inc.
$38
VIVUS LLC
$38
Bayer HealthCare Pharmaceuticals Inc.
$23
Chiesi USA, Inc.
$22
Verity Pharmaceuticals Inc.
$21
Hologic Sales and Service, LLC
$20
Horizon Therapeutics plc
$18
Astellas Pharma US Inc
$18
Nevro Corp.
$17
Mission Pharmacal Company
$17
Acella Pharmaceuticals, LLC
$15
BOSTON SCIENTIFIC CORPORATION
$14
Tolmar, Inc.
$14
Top 3 companies account for 31.9% of all-time payments
Associated products mentioned in payments ›
AFREZZA · BAQSIMI · BD Nano 2nd Gen Pen Needle · CeQur Simplicity · CitraNatal · Corlanor · Crysvita · DEXCOM G7 GSS (161) · DIABETES - DISEASE · Dexcom CGM · Dexcom G6 Transmitter · ELIQUIS · EVENITY · FARXIGA · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · GVOKE HYPOPEN · GVOKE PFS · ISTURISA · JARDIANCE · JATENZO · Kerendia · Korlym · LICART · LO LOESTRIN FE · LUX DX · MINIMED 780G · MOUNJARO · MYCAPSSA · MYCARELINK · Minimed Paradigm Revel · NP Thyroid 60 · ORILISSA · Omnia · Omnipod · Ozempic · PANCREAZE · QSYMIA · RECORLEV · RYBELSUS · Repatha · Rybelsus · SIGNIFOR LAR · SOLIQUA 100/33 · SOMAVERT · SYNJARDY · SYNTHROID · TEPEZZA · TERIPARATIDE · THINPREP 2000 PROCESSOR · TOUJEO · TRADJENTA · TZIELD · Tirosint · Tlando · Tresiba · UNITHROID · Veozah · Wegovy · XARELTO · XIGDUO · XYOSTED · iLet Bionic Pancreas · t-slim insulin pump · t:slim X2 Insulin Pump with Control-IQ · t:slim X2 insulin pump
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Endocrinologists in nearby ZIP areas
106
County median income
$68,694
Nearest hospital to ZIP centroid (approximate)
SOUTH MIAMI HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Acevedo Morales is a clinical cardiology specialist, with moderate Medicare volume, with 17 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Acevedo Morales experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Acevedo Morales performed 720 denosumab injection (prolia/xgeva) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Acevedo Morales receive payments from pharmaceutical companies?
Yes. Dr. Acevedo Morales received a total of $8,976 from 45 companies across 382 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Acevedo Morales's costs compare to other endocrinologists in South Miami?
Dr. Acevedo Morales's average Medicare payment per service is $48. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Acevedo Morales) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Endocrinology
Common procedures, typical costs, and what industry payments mean in endocrinology.
Same specialty & city
Endocrinologists in South Miami
Browse endocrinologists in South Miami ranked by procedure volume and transparency data.
Highest volume
Top Endocrinologists in FL
Endocrinologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Endocrinologists in FL
Which FL endocrinologists receive the most from drug and device companies.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology